Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 18 of 29
Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
NCT02592954
Dietary Treatments for Cognitive Impairment in Older Adults
NCT02521818
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
NCT02372591
Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia
NCT02506036
Tissue Repository for Studies of Myasthenia Gravis
NCT02902536
CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS
NCT02402218
Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends
NCT02236663
Open-label Study of Liothyronine in MS
NCT02506751
EMPower: Electronic Media Powering Positive Health Changes in Youth
NCT02444689
Sleep Apnea and Obesity Affects on Morphine Pharmacokinetics
NCT02732795
PReventing the EffectS of Intubation on DEglutition
NCT02442102
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo
NCT02506101
Study To Understand Fall Reduction and Vitamin D in You
NCT02166333
BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)
NCT02502253
Surgical Application of Vac Dressings In Obese Patients to Reduce Wound Complications
NCT02461433
Health Literacy Intervention for African Americans With Diabetes
NCT03925948
G-POEM for Treatment of Refractory Gastroparesis
NCT02732821
Aging, Cognition, and Hearing Evaluation in Elders Study
NCT02412254
Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)
NCT01942018
Study to Enhance Motor Acute Recovery With Intensive Training After Stroke
NCT02292251
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
NCT02802592
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
NCT02360371
PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration
NCT02447640
Clinical Utility of Rapid CT/NG Testing in the ED
NCT02200224
Take Charge of Burn Pain
NCT02661724
Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting
NCT02411396
Education Bundle to Decrease Patient Refusal of VTE Prophylaxis
NCT02402881
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
NCT02534233
Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography
NCT02725671
Improving Patient-Centered Care Delivery Among Patients With Chronic Obstructive Pulmonary Disease
NCT02036294
Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland
NCT02395731
Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy
NCT02426047
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)
NCT02367521
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
NCT02407340
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
NCT02243813
Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
NCT02246491
Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access
NCT03300024
Evaluation of a Tracheostomy Tube That Enables Communication
NCT02018562
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
NCT02321566
Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
NCT02517996
Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
NCT02688309
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
NCT02165111
Does Oral Acetaminophen Lower Intraocular Pressure?
NCT02366065
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077
POEM Anterior Versus Posterior Approach
NCT02454335
ReNEW Clinic Cohort Study
NCT03816462
Inflammation and Coronary Endothelial Function
NCT02366091
Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy
NCT02454153
Predictive Factors for LBP Interventional Treatment Outcomes
NCT02329951
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
NCT02410122
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.